О себе
Natalie Yivgi-Ohana, Ph.D., is an Israeli biotech executive and scientist focused on mitochondrial biology and cell therapy. She is the co-founder and CEO of Minovia Therapeutics, a clinical-stage company developing mitochondrial augmentation therapies for mitochondrial disease and age-related decline. Public sources position her as a company builder and scientific/operator figure in biotech and longevity rather than a fund manager or documented capital allocator.
Области интересов
mitochondrial biologymitochondrial diseasescell therapyrare diseasesbiomarkersaginglongevityregenerative medicinebiotech